5-aminolevulinic acid (5-ALA) is used as a drug in the photodynamic therapy (PDT) and
photodynamic diagnosis (PDD) of cancer. Combined with irradiation at the appropriate wavelength,
it is used as a photosensitizer precursor to identify/kill tumour cells. In cells, 5-aminolevulinic acid is
converted to protoporphyrin IX (PpIX), which is the precursor of hemin. Internal application of 5-ALA
induces the overproduction of the endogenous photosensitizer, PpIX, which can subsequently be activated
by light at the appropriate wavelength. 5-ALA can be applied internally to trans-mutated areas or be
injected directly into them. Chemical derivatives of 5ALA have the potential to improve bioavailability,
enhance stability and lead to better therapeutic outcomes for treated patients. 5-ALA is currently the most
commonly used drug in the photodynamic therapy and diagnosis (PDT/PDD) of cancers.
Keywords: photodynamic therapy, photodynamic diagnosis, 5-aminolevulinic acid (5- ALA), esters
of 5-aminolevulinic acid, cancer.